25-hydroxyvitamin D (25-OH D) is the best circulating marker of body vitamin D status, with a 2–3 week half-life that reflects your long-term nutritional reserve rather than acute intake. In Sweden, vitamin D status is particularly important due to high-latitude sun exposure limitations — from October through March, cutaneous synthesis is minimal at Stockholm's latitude, making dietary intake and supplementation critical for populations at risk.
Analyzed in accredited Swedish clinical laboratories (ISO 15189). Used to support clinician-directed evaluation and monitoring. Not a stand-alone diagnosis.
If you live in Sweden, spend limited time outdoors during winter, follow a plant-based diet, or have a family history of bone disease, vitamin D testing matters. This marker reveals whether your body has adequate reserve to support bone mineralization, immune regulation, and systemic health — particularly relevant during the long Nordic winter when cutaneous synthesis drops to zero.
Vitamin D deficiency is common in northern Europe and often remains undetected because symptoms are subtle: fatigue, musculoskeletal aches, impaired healing, and increased infection susceptibility can all reflect inadequate status. Testing clarifies whether these symptoms have a nutritional basis and whether supplementation is genuinely needed.
Identifies hidden deficiency before symptoms progress. Many people with insufficient vitamin D remain asymptomatic until bone mineralization falters or immune function declines — testing catches it early.
Clarifies risk for rickets and osteomalacia. Severe deficiency (< 25 nmol/L) carries real risk for metabolic bone disease; testing determines whether you're in that tier.
Guides supplementation decisions. EFSA and EASD guidance thresholds are evidence-based; testing tells you whether you actually need supplementation or are already optimal.
Contextualizes bone health markers. 25-OH D works alongside phosphate, calcium, and alkaline phosphatase to paint a complete picture of skeletal metabolism.
Reveals seasonal patterns and lifestyle impact. Testing at different times of year shows how Swedish winter affects your status and whether current dietary intake or supplementation is adequate.
Distinguishes true deficiency from other causes of symptoms. Fatigue and bone pain can come from vitamin D deficiency, but also from iron status (ferritin), thyroid dysfunction, or other metabolic factors — testing clarifies the driver.
Two forms, two jobs. Vitamin D exists in two main circulating forms: 25-hydroxyvitamin D (25-OH D), the storage form you measure in this test, and 1,25-dihydroxyvitamin D (1,25-(OH)₂D), the active hormonal form. The distinction is critical: 25-OH D reflects your body's vitamin D reserve and is the appropriate marker for status assessment. 1,25-(OH)₂D is tightly regulated by parathyroid hormone and kidney function and does not accurately reflect body stores — it can be normal even when stores are depleted.
Where it comes from. Vitamin D is synthesized in skin during summer sun exposure (UVB wavelengths), absorbed from dietary sources (oily fish, egg yolk, fortified milk, mushrooms exposed to sunlight), and can be supplemented. In the liver, both dietary and cutaneous vitamin D are hydroxylated to 25-OH D. In the kidney, 25-OH D is further hydroxylated to the active form 1,25-(OH)₂D, which regulates calcium and phosphate absorption in the intestines and resorption in bones.
Why it matters for bone and immune health. Adequate 25-OH D status is essential for intestinal calcium absorption — without it, parathyroid hormone rises to maintain serum calcium by pulling it from bone, accelerating osteoporosis. Beyond skeletal health, vitamin D receptors are present in immune cells, endothelial cells, and other tissues; deficiency impairs pathogen recognition and adaptive immune responses, increasing susceptibility to infection, and may contribute to autoimmune dysregulation.
Prevents metabolic bone disease in deficiency. Severe deficiency (< 25 nmol/L) drives rickets in children and osteomalacia in adults — impaired bone mineralization, proximal muscle weakness, and fracture risk. Correcting true deficiency is evidence-backed and uncontroversial.
Optimizes bone turnover markers. Adequate 25-OH D status keeps parathyroid hormone suppressed and calcium homeostasis stable, reducing unnecessary bone resorption and supporting skeletal integrity with age.
Supports robust innate immunity. Vitamin D deficiency impairs antimicrobial peptide production in macrophages and impairs T-cell differentiation — populations with deficiency have higher rates of respiratory and other infections.
Contextualizes supplementation response. The VITAL trial (a large 2022 RCT) found that vitamin D supplementation in non-deficient populations did not reduce cardiovascular events or cancer incidence — highlighting that the benefit of correction applies to people with genuine deficiency, not routine universal supplementation in replete adults.
Severe deficiency: < 25 nmol/L (rickets/osteomalacia risk, immediate clinical concern).
Insufficiency: 25–49 nmol/L (suboptimal for bone turnover and immune regulation; supplementation typically indicated).
Sub-optimal: 50–74 nmol/L (functional adequacy but room for improvement, particularly relevant before Swedish winter).
Loovi optimal range: 75–125 nmol/L (balances evidence-based skeletal and immune support with practical achievability in northern latitude).
High: 125–250 nmol/L (excess reserve; no additional benefit demonstrated and not problematic unless sustained).
Toxic: > 250 nmol/L (rare, requires prolonged mega-dosing; risk of hypercalcemia and soft-tissue calcification).
Risk of deficiency-related bone disease rises below 50 nmol/L. Between 50–75 nmol/L, bone metabolism is functional but suboptimal. The Loovi target of 75–125 nmol/L aligns with EFSA and EASD guidance for sustained skeletal and immune support without unnecessary excess.
Low (below 50 nmol/L). This reflects inadequate circulating reserve and typically indicates either insufficient sun exposure, limited dietary intake, or both. At this level, parathyroid hormone rises to maintain serum calcium by mobilizing bone — a signal of metabolic stress. Intestinal calcium absorption is impaired, increasing fracture risk and skeletal fragility. Immune cell function is compromised. This tier warrants supplementation and dietary review, particularly in winter months.
Optimal (75–125 nmol/L). This reflects adequate nutritional reserve for bone mineralization, calcium homeostasis, and immune regulation. At this level, parathyroid hormone is suppressed, bone turnover is balanced, and immune function is supported. This is the target range for long-term skeletal and systemic health.
High (125–250 nmol/L). This reflects ample reserve — common in people with high summer sun exposure or consistent supplementation. No additional health benefit is demonstrated above 125 nmol/L, but this range is not harmful and does not require intervention.
Very high (> 250 nmol/L). This is rare and typically requires prolonged high-dose supplementation or excessive sun exposure. Risk of hypercalcemia and ectopic soft-tissue and vascular calcification rises. Supplementation should be reassessed and reduced.
Factors that influence vitamin D levels. Latitude and season are dominant: northern locations and winter months dramatically reduce cutaneous synthesis. Skin pigmentation (melanin) reduces UVB penetration — darker-skinned individuals in high-latitude regions are at particular risk. Age and kidney function also matter — renal hydroxylation efficiency declines with age and renal disease. Dietary sources (oily fish, egg yolk, fortified dairy) contribute modestly. Fat malabsorption (celiac disease, Crohn's disease, cystic fibrosis) impairs vitamin D uptake. Medications (anticonvulsants, glucocorticoids) can accelerate metabolism.
Geographic location and seasonality. At Stockholm's latitude (59°N), cutaneous vitamin D synthesis is minimal from October through March. Southern European and equatorial populations maintain higher year-round synthesis. Winter-dominant deficiency is expected and preventable with supplementation.
Skin pigmentation and sun exposure behavior. Melanin reduces UVB penetration — people with darker skin require 3–10 times longer sun exposure for equivalent synthesis. Time spent indoors (occupational or lifestyle) reduces exposure. Use of sunscreen (necessary for skin cancer prevention) blocks UVB but is appropriate in summer.
Dietary intake. Few foods are naturally rich in vitamin D (fatty fish, egg yolk). Most dietary D comes from fortified sources (some dairy, plant-based milks, breakfast cereals) which vary by country. Vegans and people avoiding fortified foods are at higher risk.
Malabsorption and metabolic disease. Celiac disease, Crohn's disease, cystic fibrosis, and severe steatorrhea impair fat-soluble vitamin absorption. Chronic kidney disease impairs the final hydroxylation step; severe liver disease impairs 25-hydroxylation (rare but clinically relevant).
Age and declining renal function. Renal 1α-hydroxylase activity declines with age, and eGFR naturally drops, reducing active vitamin D synthesis even when 25-OH D is adequate — older adults need higher baseline 25-OH D to maintain the same active form.
Sunlight exposure (summer and autumn). Peak UVB synthesis occurs at midday (10am–3pm), roughly May through September at northern latitudes. 15–30 minutes of midday sun exposure on exposed skin (face, arms, legs) several times per week can contribute meaningfully to vitamin D stores, though this alone is insufficient to carry you through winter at Swedish latitudes. Sunscreen for skin cancer prevention is appropriate and does not entirely block synthesis.
Dietary sources. Oily fish (salmon, mackerel, herring) contain 10–25 µg per 100 g serving. Egg yolk contains ~1.5 µg per egg. Mushrooms exposed to sunlight contain more than those grown in the dark. Fortified dairy and plant-based milk alternatives contribute 1–2.5 µg per serving. These sources matter but are unlikely to achieve optimal status in winter without supplementation.
Supplementation mechanisms. Vitamin D supplementation is absorbed with dietary fat in the small intestine and hydroxylated in the liver to 25-OH D. Adequate intake for deficiency correction is determined by baseline status, body weight, and target level — dosing is individualized and falls outside the scope of this reference page. Vitamin D toxicity requires sustained very-high-dose intake (typically > 10,000 IU daily for months); physiologic dosing for deficiency correction is safe and evidence-backed.
Supporting factors. Adequate calcium and phosphate intake supports bone turnover; adequate renal function and lower age support efficient hydroxylation. Exercise (particularly weight-bearing and resistance training) stimulates bone formation and synergizes with vitamin D status. Sleep and systemic inflammation modulate immune responses to vitamin D signaling.
Optimizing vitamin D is straightforward — correct genuine deficiency with supplementation, ensure adequate calcium and phosphate intake, and support bone and immune health through the full Loovi lens: sleep, training, nutrition, and systemic inflammation markers work together. A longevity doctor maps this out in consultation.
Vitamin D doesn't exist in a vacuum — it works as part of a bone health and immune system coalition. Testing vitamin D alone without calcium, phosphate, and alkaline phosphatase (ALP) leaves you guessing about actual bone turnover and mineralization. Is your skeleton remodeling normally, or is there silent osteoporosis building? Ferritin matters too — iron deficiency impairs immune responses and complicates the interpretation of infection risk. Albumin contextualizes how much free (active) vitamin D you're carrying. And in the metabolic picture, thyroid status, glucose control (HbA1c), and systemic inflammation (hs-CRP) all affect how your body responds to vitamin D signaling and how your bones adapt to mechanical load.
This is exactly why Loovi tracks 120+ biomarkers annually — not to overwhelm you with numbers, but to paint the full picture. Your vitamin D status is one piece of your bone, immune, and longevity puzzle. A Loovi longevity doctor contextualizes your results against your complete metabolic profile, physical performance data, and genetics, then builds a personalized health plan that actually moves the needle. Book a consultation to interpret your vitamin D in the context that matters.
1,25-(OH)₂D is the active hormonal form, but it's tightly regulated by parathyroid hormone and kidney function — it can remain normal even when body stores are severely depleted. 25-OH D reflects your actual vitamin D reserve and is the standard for status assessment in all major guidelines (EFSA, EASD, Endocrine Society). Testing 1,25-(OH)₂D alone would miss deficiency entirely.
At Swedish latitudes, outdoor time during winter (October–March) does not produce cutaneous synthesis; UVB intensity is too low. If you work indoors and sunbathe only weekends, winter synthesis is insufficient even with lifestyle effort. Skin pigmentation also reduces synthesis efficiency — darker-skinned individuals require much longer exposure. Low vitamin D in this context is expected, not a sign of failure, and is corrected with supplementation.
25-OH D has a 2–3 week half-life, meaning it takes roughly 2–3 months of consistent supplementation to reach a new steady state. The speed depends on baseline deficit and supplementation dose — larger deficits require higher sustained intake. Acute high-dose supplementation (e.g., a single large injection) achieves rapid raises but doesn't reflect steady oral supplementation. Renal function and body fat distribution (vitamin D is fat-soluble) also influence the rate of change.
No. The VITAL trial (2022) showed that vitamin D supplementation in non-deficient populations did not reduce cardiovascular events or cancer incidence — a landmark result that revised enthusiasm for universal supplementation in replete adults. The benefit of vitamin D correction applies to people with genuine deficiency (< 50 nmol/L) or insufficiency (50–75 nmol/L), particularly in Swedish winters and in darker-skinned individuals. Routine supplementation in people already at optimal status (> 75 nmol/L) is not evidence-backed.
Essentially no. Even oily fish (the richest natural source) contains only 20–25 µg per serving — you'd need to eat salmon daily for months to reach toxic levels. Toxicity is a supplementation phenomenon, typically requiring sustained doses > 10,000 IU daily for months, and is rare in clinical practice.
Yes. Vitamin D receptors are present in T cells, B cells, macrophages, and dendritic cells. Deficiency impairs antimicrobial peptide production, T-cell differentiation, and Th1/Th2 balance — all of which can amplify susceptibility to infection and may contribute to autoimmune dysregulation in genetically predisposed individuals. Adequate status (75–125 nmol/L) supports balanced innate and adaptive immune function.
Testing after winter (March–April) captures your lowest annual point and most accurately reflects whether supplementation during winter was adequate. Testing in late summer (August–September) shows whether sun exposure and dietary intake sustained you through summer. Many people track both to understand their seasonal pattern — testing twice yearly is a reasonable longevity practice in Sweden.
Vitamin D testing is not standard-of-care at most vårdcentral clinics unless symptoms of deficiency are present (musculoskeletal pain, suspected rickets or osteomalacia). Preventive vitamin D testing is available through private longevity services like Loovi, which also contextualizes your result alongside bone markers (calcium, phosphate, ALP), iron status (ferritin), and immune markers (hs-CRP).
Vitamin D is one driver of energy and immune resilience, but fatigue has many causes. Ferritin (iron status and energy), thyroid function (TSH, fT4), systemic inflammation (hs-CRP), sleep quality, training recovery, and glucose control (HbA1c) all influence energy. A complete longevity assessment rules out these other factors rather than attributing fatigue to vitamin D alone.
